GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fredun Pharmaceuticals Ltd (BOM:539730) » Definitions » Long-Term Debt

Fredun Pharmaceuticals (BOM:539730) Long-Term Debt : ₹0 Mil (As of Jun. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Fredun Pharmaceuticals Long-Term Debt?

Fredun Pharmaceuticals's Long-Term Debt for the quarter that ended in Jun. 2024 was ₹0 Mil.

Fredun Pharmaceuticals's quarterly Long-Term Debt increased from Dec. 2023 (₹0 Mil) to Mar. 2024 (₹128 Mil) but then declined from Mar. 2024 (₹128 Mil) to Jun. 2024 (₹0 Mil).

Fredun Pharmaceuticals's annual Long-Term Debt declined from Mar. 2022 (₹420 Mil) to Mar. 2023 (₹154 Mil) and declined from Mar. 2023 (₹154 Mil) to Mar. 2024 (₹128 Mil).

Fredun Pharmaceuticals Long-Term Debt Historical Data

The historical data trend for Fredun Pharmaceuticals's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fredun Pharmaceuticals Long-Term Debt Chart

Fredun Pharmaceuticals Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 114.96 291.11 420.39 154.40 127.98

Fredun Pharmaceuticals Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 135.96 - 127.98 -

Fredun Pharmaceuticals  (BOM:539730) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Fredun Pharmaceuticals Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Fredun Pharmaceuticals's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Fredun Pharmaceuticals Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fredun Pharmaceuticals Ltd (BOM:539730) » Definitions » Long-Term Debt
Comparable Companies
BOM:526953 BOM:530477 BOM:532039 BOM:524500 BOM:541096 BOM:539997 BOM:524654 BOM:532408 BOM:500009 BOM:524075 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
Ganpatrao Kadam Marg, 11th Floor, Urmi Estate, Lower Parel (West), Mumbai, MH, IND, 400013
Website
http://www.fredungroup.com
Fredun Pharmaceuticals Ltd is an India based company engaged in the business of pharmaceuticals and healthcare. The company manufactures pharmaceutical formulations, nutraceuticals, herbal supplements, and dietary supplements. In addition, it also manufactures animal healthcare products through its group companies. It sells its products in India and also exports its formulations as branded generics to international countries.

Fredun Pharmaceuticals Headlines

No Headlines